Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Optimizing Treatment of Rheumatoid Arthritis: A Case Study
Link ID 502
Title Optimizing Treatment of Rheumatoid Arthritis: A Case Study
Url http://www.medscape.com/viewprogram/7162?src=rss
Description
Category Articles > Rheumatology
Keywords
Date Nov 6, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Rheumatology
1. Evaluating the Adequacy of Disease Control in Patients With Rheumatoid Arthritis: A RAND Appropriate
  A panel of rheumatologists was convened to develop guidelines to assess adequacy of disease control, focusing on the use of disease-modifying anti-rheumatic drugs.
Rheumatology
Category:   Articles > Rheumatology


2. Ambrisentan: A New Drug for Pulmonary Arterial Hypertension
  Ambrisentan, a diphenyl propionic acid derivative, represents a valuable addition to the treatment alternatives for this orphan disease
AccessMedicine from McGraw-Hill
Category:   Articles > Rheumatology


3. Safe Adalimumab Therapy for Rheumatoid Arthritis in a Patient With Pre-existing Multiple Myeloma
  Rheumatoid arthritis is treated effectively with anti-tumor necrosis factor but with a possible risk of malignancy. How might treatment be safe and effective in patients with preexisting malignancies?
Nature Clinical Practice Rheumatology
Category:   Articles > Rheumatology


4. Non-Hodgkin Lymphoma Risk Increased by Some Autoimmune Disorders
  The risk of developing non-Hodgkin lymphoma (NHL) is increased in certain, but not all, autoimmune disorders, according to a report in the April 15th issue of Blood. Reuters Health Information
Category:   Articles > Rheumatology


5. Growth Hormone Therapy May Benefit Some Fibromyalgia Patients
  In fibromyalgia patients with severe disease and low serum levels of insulin-like growth factor 1 (IGF-1), adding daily subcutaneous injections of growth hormone to standard intensive therapy reduces pain and improves quality of life, results of a pilot study suggest. Reuters Health Information
Category:   Articles > Rheumatology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS